Evolent Health, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Evolent Health, Inc. (EVH) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$11.35 million for the 3-month period ending 2022-12-31, per its 10-K filed 2024-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-02-23
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$11.35M, a 471.73% decline year-over-year.
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was $2.12M.
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$4.13M.
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$5.35M.
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$30.28M.
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$328.17M.
- Evolent Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was -$307.19M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$11.35M 10-K · filed 2024-02-23 | -$9.23M derived: sum of 2 quarters · filed 2024-02-23 | -$13.35M derived: sum of 3 quarters · filed 2024-02-23 | -$18.70M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-09-30 | $2.12M 10-K · filed 2024-02-23 | -$2.00M derived: sum of 2 quarters · filed 2024-02-23 | -$7.35M derived: sum of 3 quarters · filed 2024-02-23 | -$4.30M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | -$4.13M 10-K · filed 2024-02-23 | -$9.47M derived: sum of 2 quarters · filed 2024-02-23 | -$6.42M derived: sum of 3 quarters · filed 2024-02-23 | -$19.46M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | -$5.35M 10-K · filed 2024-02-23 | -$2.30M derived: sum of 2 quarters · filed 2024-02-23 | -$15.34M derived: sum of 3 quarters · filed 2024-02-23 | -$24.44M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $3.05M 10-K · filed 2023-02-24 | -$9.99M derived: sum of 2 quarters · filed 2023-02-24 | -$19.09M derived: sum of 3 quarters · filed 2023-02-24 | -$30.28M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$13.04M 10-K · filed 2023-02-24 | -$22.15M derived: sum of 2 quarters · filed 2023-02-24 | -$33.34M 10-Q · filed 2021-11-04 | -$43.97M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | -$9.11M 10-K · filed 2023-02-24 | -$20.30M 10-Q · filed 2021-08-05 | -$30.93M derived: sum of 3 quarters · filed 2023-02-24 | -$67.97M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | -$11.19M 10-K · filed 2023-02-24 | -$21.83M derived: sum of 2 quarters · filed 2023-02-24 | -$58.86M derived: sum of 3 quarters · filed 2023-02-24 | -$260.88M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | -$10.64M 10-K · filed 2022-02-24 | -$47.67M derived: sum of 2 quarters · filed 2022-02-24 | -$249.69M derived: sum of 3 quarters · filed 2022-02-24 | -$328.17M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$37.03M 10-K · filed 2022-02-24 | -$239.05M derived: sum of 2 quarters · filed 2022-02-24 | -$317.54M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$202.01M 10-K · filed 2022-02-24 | -$280.50M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$78.49M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | -$307.19M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |